1. Epidemiology
Indicator
|
Recommended disaggregations
|
1.1 Yearly age-specific incidence rates of all episodes, and of first episodes of ARF according to
|
1.1.1 Sex
1.1.2 Ethnicity
|
1.2 Proportion of all recorded ARF episodes classified as recurrences
|
..
|
1.3 Rates of ARF recurrences per 100 patient-years
|
..
|
1.4 Number of deaths and age-standardised rates of mortality due to ARF and RHD in the previous calendar year by ethnicity
|
..
|
1.5 Yearly age-specific and overall incidence of RHD by ethnicity and broken down by method found and presented
|
..
|
1.6 Yearly age-specific prevalence of RHD, by ethnicity
|
..
|
1.7 Proportion of newly registered cases of ARF or RHD with an initial recorded diagnosis being established RHD (rather than ARF)
|
..
|
2. Requirement and uptake of secondary prophylaxis
Indicator
|
Recommended disaggregations
|
2.1 Proportion of all people indicated for secondary prophylaxis* who are registered to receive benzathine penicillin G (BPG).
|
.. |
2.2 Median percentage of all scheduled BPG doses actually delivered
|
..
|
2.3 Proportion of people indicated for BPG secondary prophylaxis who received <50%, 50-79%, and ≥80% of scheduled doses in the previous calendar year
|
..
|
3. Quality of management
Indicator
|
Recommended disaggregations
|
3.1 Proportion of all registered ARF and RHD cases classified as mild, moderate, severe and inactive
|
..
|
3.2 Proportion of people classified as moderate or severe RHD who had an echocardiogram within the previous 6 months, 1 year, and 1-2 years
|
..
|
3.3 Number of cases, and proportion of total cases indicated for cardiac surgery, who have been waiting <6 months, 6-11 months, 12-23 months, or 24+ months
|
..
|
3.4 Number and type of surgical procedures performed during the previous calendar year by
|
3.4.1 Age group
3.4.2 Ethnicity
|
3.5 Number (and proportion) of people who died in the previous calendar year within 28 days and 1 year of undergoing rheumatic cardiac surgery by
|
3.5.1 Age group
3.5.2 Ethnicity
|
* If denominator of those indicated for prophylaxis not known, use people with a history of ARF within the last 10 years, or, ARF and RHD and aged < 21 years, or, aged ≥21 years with moderate or severe RHD.
Source: RHD Australia (ARF/RHD writing group) 2012.